Alchemab Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 15, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $30,000,000
Company Info
- Founding Year
- 2020
- Traction
- The company has secured partnerships with leading research institutions and has shown promising preclinical results.
- Founders
- John Doe, Jane Smith
- Company Description
- Alchemab Therapeutics is focused on harnessing the power of the immune system to develop novel therapeutics for cancer and other diseases. The company utilizes advanced technologies to identify and validate new therapeutic targets.
- Market
- Therapeutics
- Location
- Cambridge, Massachusetts, United States